These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 22692501)
1. Low-protein diet improves blood and urinary glucose levels and renal manifestations of diabetes in C57BLKS-db/db mice. Arimura E; Horiuchi M; Kawaguchi H; Miyoshi N; Aoyama K; Takeuchi T Eur J Nutr; 2013 Mar; 52(2):813-24. PubMed ID: 22692501 [TBL] [Abstract][Full Text] [Related]
2. Deteriorated glucose metabolism with a high-protein, low-carbohydrate diet in db mice, an animal model of type 2 diabetes, might be caused by insufficient insulin secretion. Arimura E; Pulong WP; Marchianti ACN; Nakakuma M; Abe M; Ushikai M; Horiuchi M Eur J Nutr; 2017 Feb; 56(1):237-246. PubMed ID: 26497335 [TBL] [Abstract][Full Text] [Related]
3. Altering dietary protein type and quantity reduces urinary albumin excretion without affecting plasma glucose concentrations in BKS.cg-m +Lepr db/+Lepr db (db/db) mice. Teixeira SR; Tappenden KA; Erdman JW J Nutr; 2003 Mar; 133(3):673-8. PubMed ID: 12612136 [TBL] [Abstract][Full Text] [Related]
4. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. Park CW; Zhang Y; Zhang X; Wu J; Chen L; Cha DR; Su D; Hwang MT; Fan X; Davis L; Striker G; Zheng F; Breyer M; Guan Y Kidney Int; 2006 May; 69(9):1511-7. PubMed ID: 16672921 [TBL] [Abstract][Full Text] [Related]
5. Higher Branched-chain Amino Acids and Lower Serine Exist in the Plasma of Nondiabetic Mice: A Comparison Between High- and Low-protein Diet Conditions. Arimura E; Ushikai M; Horiuchi M In Vivo; 2021; 35(3):1555-1560. PubMed ID: 33910835 [TBL] [Abstract][Full Text] [Related]
6. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis. Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051 [TBL] [Abstract][Full Text] [Related]
7. Effects of Diets with Different Proportions of Protein/Carbohydrate on Retinal Manifestations in Arimura E; Okatani H; Araki T; Ushikai M; Nakakuma M; Abe M; Kawaguchi H; Izumi H; Horiuchi M In Vivo; 2018; 32(2):265-272. PubMed ID: 29475908 [TBL] [Abstract][Full Text] [Related]
8. Tofogliflozin, a novel sodium-glucose co-transporter 2 inhibitor, improves renal and pancreatic function in db/db mice. Nagata T; Fukuzawa T; Takeda M; Fukazawa M; Mori T; Nihei T; Honda K; Suzuki Y; Kawabe Y Br J Pharmacol; 2013 Oct; 170(3):519-31. PubMed ID: 23751087 [TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Tonra JR; Ono M; Liu X; Garcia K; Jackson C; Yancopoulos GD; Wiegand SJ; Wong V Diabetes; 1999 Mar; 48(3):588-94. PubMed ID: 10078561 [TBL] [Abstract][Full Text] [Related]
10. Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095. Arakawa K; Ishihara T; Oku A; Nawano M; Ueta K; Kitamura K; Matsumoto M; Saito A Br J Pharmacol; 2001 Jan; 132(2):578-86. PubMed ID: 11159708 [TBL] [Abstract][Full Text] [Related]
12. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748 [TBL] [Abstract][Full Text] [Related]
13. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Schwartz MW; Baskin DG; Bukowski TR; Kuijper JL; Foster D; Lasser G; Prunkard DE; Porte D; Woods SC; Seeley RJ; Weigle DS Diabetes; 1996 Apr; 45(4):531-5. PubMed ID: 8603777 [TBL] [Abstract][Full Text] [Related]
14. Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice. Jia Y; He J; Wang L; Su L; Lei L; Huang W; Geng X; Zhang S; Meng X; Zhou H; Yang B Cell Physiol Biochem; 2018; 45(5):1747-1758. PubMed ID: 29495021 [TBL] [Abstract][Full Text] [Related]
15. Effect of long-term dietary arginyl-fructose (AF) on hyperglycemia and HbA1c in diabetic db/db mice. Lee KH; Ha KS; Jo SH; Lee CM; Kim YC; Chung KH; Kwon YI Int J Mol Sci; 2014 May; 15(5):8352-9. PubMed ID: 24823880 [TBL] [Abstract][Full Text] [Related]
16. Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice. Tomaru M; Takano H; Osakabe N; Yasuda A; Inoue K; Yanagisawa R; Ohwatari T; Uematsu H Nutrition; 2007 Apr; 23(4):351-5. PubMed ID: 17350804 [TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice. Orland MJ; Permutt MA Diabetes; 1987 Mar; 36(3):341-7. PubMed ID: 3542656 [TBL] [Abstract][Full Text] [Related]
18. High protein weight loss diets in obese subjects with type 2 diabetes mellitus. Pedersen E; Jesudason DR; Clifton PM Nutr Metab Cardiovasc Dis; 2014 May; 24(5):554-62. PubMed ID: 24374004 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Bindom SM; Hans CP; Xia H; Boulares AH; Lazartigues E Diabetes; 2010 Oct; 59(10):2540-8. PubMed ID: 20660625 [TBL] [Abstract][Full Text] [Related]